Ondine Biomedical Inc (LON:OBIMF) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

BRIEF

published on 10/28/2024 at 08:05, 24 days 2 hours ago

Ondine Biomedical Advances Steriwave Commercialization

Antimicrobial Resistance Ondine Biomedical Steriwave Technology Healthcare-associated Infections Innovation In Healthcare
PRESS RELEASE

published on 10/28/2024 at 08:00, 24 days 2 hours ago

Ondine Continues Commercial Growth
Ondine Biomedical Inc. provides updates on the commercial roll-out of its Steriwave® nasal decolonization technology, reducing healthcare-associated infections with light-activated treatment

Ondine Biomedical Inc. Nasal Decolonization Steriwave Healthcare-associated Infections Antimicrobial Treatments
BRIEF

published on 10/23/2024 at 08:05, 29 days 2 hours ago

Ondine Biomedical Inc. Launches Steriwave Pilot at King's College Hospital

Steriwave Healthcare Innovation Ondine Biomedical Antimicrobial Treatment King's College Hospital
PRESS RELEASE

published on 10/23/2024 at 08:00, 29 days 2 hours ago

Ondine Biomedical Inc. Announces King's College Hospital to Run Steriwave Pilot
Ondine Biomedical Inc. collaborates with King's College Hospital to pilot Steriwave® light-activated antimicrobial tech for preventing HAIs. Steriwave rapidly eliminates pathogens without resistance

Ondine Biomedical Inc. Steriwave Hospital-acquired Infections Antimicrobial Technology King's College Hospital
BRIEF

published on 09/30/2024 at 11:10, 1 month 20 days ago

Ondine Biomedical Reports Robust Growth in H1 2024

Clinical Trials Steriwave Ondine Biomedical Financial Growth Hospital Adoption
PRESS RELEASE

published on 09/30/2024 at 11:05, 1 month 20 days ago

Ondine Biomedical Reports Robust Growth in H1 2024
Ondine Biomedical Inc. reports unaudited operational and financial results for the first half of 2024, showing strong revenue growth and strategic partnerships

Financial Performance Ondine Biomedical Inc. Strategic Partnership Clinical Trials Operational Results
BRIEF

published on 09/30/2024 at 08:05, 1 month 21 days ago

Ondine Biomedical Reports Robust Growth in H1 2024

Financial Results Clinical Trials Ondine Biomedical Steriwave® H1 2024
PRESS RELEASE

published on 09/30/2024 at 08:00, 1 month 21 days ago

Ondine Biomedical Reports Robust Growth in H1 2024
Ondine Biomedical reports unaudited strong operational and financial results for the first half of 2024, including revenue growth and strategic partnerships

Financial Results Strategic Partnership Ondine Biomedical Operational Highlights Clinical Endeavors
BRIEF

published on 09/25/2024 at 08:05, 1 month 26 days ago

Ondine Biomedical Inc. Announces Collaboration to Advance Steriwave for ICU Market

Ondine Biomedical Inc. Steriwave Infection Prevention ICUs RCH Foundation
PRESS RELEASE

published on 09/25/2024 at 08:00, 1 month 26 days ago

Ondine Biomedical Inc. Announces Collaboration advances Steriwave for ICU Market
Ondine Biomedical partners with Royal Columbian Hospital Foundation's AIM division for clinical trials on Steriwave ICU use, aiming to reduce infections and improve patient outcomes in critical care settings

Clinical Trials Ondine Biomedical Infection Prevention Royal Columbian Hospital Foundation Steriwave ICU

1 2 ... 6

Accesswire

Published on 11/21/2024 at 10:03, 25 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 28 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 28 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 53 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 3 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 23 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 26 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 28 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 28 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 27 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 30 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 8 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 43 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 43 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE